Molson Coors Beverage Company (TAP) Stock Forecast
Data as of Sep 16, 2026Consumer Defensive · Current price $39.02 (-0.61%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 5, 2025 | Robert Ottenstein | Evercore ISI | $50.00 | +28.1% |
| Nov 4, 2025 | Kaumil Gajrawala | Jefferies | $48.00 | +23.0% |
| Oct 8, 2025 | Peter Grom | UBS | $49.00 | +25.6% |
| Sep 30, 2025 | Michael Lavery | Piper Sandler | $52.00 | +33.3% |
| May 20, 2025 | William Kirk | Roth Capital | $71.00 | +82.0% |
| Mar 27, 2025 | Lauren Lieberman | Barclays | $61.00 | +56.3% |
| Nov 8, 2024 | Chris Carey | Wells Fargo | $74.00 | +89.6% |
| Aug 7, 2024 | Michael Lavery | Piper Sandler | $59.00 | +51.2% |
| Jul 19, 2024 | Michael Lavery | Piper Sandler | $57.00 | +46.1% |
| Jul 18, 2024 | Lauren Lieberman | Barclays | $47.00 | +20.5% |
| Jul 14, 2024 | Trevor Stirling | Bernstein | $61.00 | +56.3% |
| Apr 30, 2024 | Robert Ottenstein | Evercore ISI | $68.00 | +74.3% |
| Apr 12, 2024 | Lauren Lieberman | Barclays | $67.00 | +71.7% |
| Apr 9, 2024 | Bonnie Herzog | Goldman Sachs | $75.00 | +92.2% |
| Mar 22, 2024 | Michael Lavery | Piper Sandler | $69.00 | +76.8% |
| Dec 6, 2022 | Steve Powers | Deutsche Bank | $50.00 | +28.1% |
| Sep 1, 2022 | Nikolaas Faes | Bryan Garnier & Co Ltd | $54.00 | +38.4% |
| Jun 28, 2022 | Bonnie Herzog | Goldman Sachs | $54.00 | +38.4% |
| Jun 24, 2022 | Vivien Azer | Cowen & Co. | $55.00 | +41.0% |
| Feb 24, 2022 | William Kirk | MKM Partners | $64.00 | +64.0% |
Top Analysts Covering TAP
TAP vs Sector & Market
| Metric | TAP | Consumer Defensive Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 3.06 | 2.56 | 2.42 |
| Analyst Count | 16 | 10 | 18 |
| Target Upside | +9.9% | +1204.8% | +19.5% |
| P/E Ratio | -3.88 | 13.60 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $11.01B | $11.14B | $11.21B | 15 |
| 2027-03-31 | $2.28B | $2.32B | $2.35B | 4 |
| 2027-06-30 | $3.12B | $3.17B | $3.21B | 4 |
| 2027-09-30 | $2.88B | $2.93B | $2.98B | 5 |
| 2027-12-31 | $2.59B | $2.63B | $2.67B | 4 |
| 2028-03-31 | $2.29B | $2.33B | $2.36B | 3 |
| 2028-06-30 | $3.09B | $3.14B | $3.19B | 3 |
| 2028-09-30 | $2.87B | $2.92B | $2.96B | 5 |
| 2028-12-31 | $2.62B | $2.66B | $2.70B | 3 |
| 2029-12-31 | $11.05B | $11.28B | $11.48B | 12 |
| 2030-12-31 | $11.32B | $11.56B | $11.77B | 6 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $4.50 | $4.69 | $5.08 | 12 |
| 2027-03-31 | $0.39 | $0.40 | $0.40 | 4 |
| 2027-06-30 | $1.83 | $1.87 | $1.91 | 4 |
| 2027-09-30 | $1.55 | $1.58 | $1.61 | 4 |
| 2027-12-31 | $1.07 | $1.09 | $1.11 | 4 |
| 2028-03-31 | $0.45 | $0.46 | $0.47 | 5 |
| 2028-06-30 | $1.95 | $1.99 | $2.03 | 5 |
| 2028-09-30 | $1.67 | $1.71 | $1.74 | 5 |
| 2028-12-31 | $1.20 | $1.23 | $1.25 | 5 |
| 2029-12-31 | $5.68 | $5.84 | $5.97 | 4 |
| 2030-12-31 | $5.98 | $6.14 | $6.28 | 2 |
Frequently Asked Questions
What is the analyst consensus for TAP?
The consensus among 16 analysts covering Molson Coors Beverage Company (TAP) is Hold with an average price target of $45.56.
What is the highest price target for TAP?
The highest price target for TAP is $75.00, set by Bonnie Herzog at Goldman Sachs on 2024-04-09.
What is the lowest price target for TAP?
The lowest price target for TAP is $42.00, set by Bonnie Herzog at Goldman Sachs on 2021-10-29.
How many analysts cover TAP?
16 analysts have issued ratings for Molson Coors Beverage Company in the past 12 months.
Is TAP a buy or sell right now?
Based on 16 analyst ratings, TAP has a consensus rating of Hold (3.06/5) with a +9.9% upside to the consensus target of $45.56.
What are the earnings estimates for TAP?
Analysts estimate TAP will report EPS of $4.69 for the period ending 2026-12-31, with revenue estimated at $11.14B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.